COVID – Cheap miracle cure for serious illness

A blood thinner worth 6,000 forints can help Covid patients: it can prevent lung damage.

Researchers in the UK and Australia have found that a blood thinner called heparin has improved the oxygen levels in hospital patients by 70 per cent. Experts say the drug is unique because of its combination of antiviral, anti-inflammatory and anticoagulant effects and is already being used in hospitals to prevent blood clots in infected Britons. It is usually given by injection, but doctors have found it to be safe and effective for Covid patients to inhale, reports Glance.

Photo by

According to experts, the drug works by preventing the virus from multiplying in the lungs, while its anti-inflammatory properties prevent the immune system from overreacting.

The coronavirus can be fatal because it can damage the lungs, which blocks the flow of oxygen in the body, and can cause blood clots in the lungs of more severe patients. As a result, the drug could be very effective, and doctors say it could be used in poorer countries where fewer people have been vaccinated, so the risk of hospital treatment is higher, the Daily Mail reports.

Frank van Haren Professor, author of a study at the National University of Australia, said: The drug is now available to hospitals around the world and is very cheap. If as effective as our early results suggest, it could have a big impact on the fight against Covid.

Clive Page Professor, a researcher at ANU and King’s College London, added:

Heparin effectively inhibits the cells that infect the virus in the lungs and can also prevent people from catching the virus from others. It also acts as an anti-inflammatory, the medicine can have a calming effect when the body responds excessively to the virus. It is already known that heparin may reduce the lung damage caused by inflammation and the excessive driving force of the immune response seen in other lung diseases, which may also be beneficial in patients hospitalized with the coronavirus.

Photo by

He also pointed out that there is no other drug that has these three different effects: antiviral, anti-inflammatory, and anticoagulant.

A study published in the British Journal of Clinical Pharmacology analyzed 98 hospital-infected Covid patients who received heparin in the United States and Argentina between April 2020 and January 2021.

The mean age of the patients in the study was 66 years, most of whom were not ventilated. Nearly two-thirds of them have already received an antiviral drug that has been approved for emergency use in Covid patients in the UK.

The researchers measured the levels of oxygen in the blood before and after the medicine was given at three different doses. The results showed an increase in oxygen levels in all groups after taking the drug. A total of 69 patients (70 percent) survived the virus and 29 (30 percent) died. The improvement in oxygen levels helped survivors avoid being placed on a ventilator.

Read this too!

This thing can reduce the risk of severe COVID by 60 percent

Source: Napidoktor by

*The article has been translated based on the content of Napidoktor by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!